Covered recipient · General Payments record
AROBA SADAF
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$789.75
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.76 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $85.79 | 3 |
| Novo Nordisk AS | $80.05 | 5 |
| Lilly USA, LLC | $50.28 | 3 |
| PFIZER INC. | $45.93 | 3 |
| Acerta Pharma LLC | $38.81 | 2 |
| Exact Sciences Corporation | $27.90 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.87 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105996777 | CMS |
| ABBVIE INC. | $22.71 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105996779 | CMS |
| ABBVIE INC. | $31.21 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105996781 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.75 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104487176 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.06 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105823633 | CMS |
| Exact Sciences Corporation | $13.82 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114867748 | CMS |
| Exact Sciences Corporation | $14.08 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114867759 | CMS |
| Lilly USA, LLC | $17.94 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136064062 | CMS |
| Lilly USA, LLC | $15.07 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136056382 | CMS |
| Lilly USA, LLC | $17.27 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136064064 | CMS |
| Novo Nordisk Inc | $14.74 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096731612 | CMS |
| Novo Nordisk Inc | $15.32 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097819412 | CMS |
| Novo Nordisk Inc | $16.43 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097826343 | CMS |
| Novo Nordisk Inc | $13.46 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096971115 | CMS |
| Novo Nordisk Inc | $20.10 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096706676 | CMS |
| PFIZER INC. | $14.88 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131717088 | CMS |
| PFIZER INC. | $17.44 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131715932 | CMS |
| PFIZER INC. | $13.61 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131712459 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.